These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 6147109)

  • 41. Dissociation of the responses of the renin-angiotensin system and sympathetic nervous system to a vasodilator stimulus in congestive heart failure.
    Levine TB; Olivari MT; Cohn JN
    Int J Cardiol; 1986 Aug; 12(2):165-73. PubMed ID: 3744598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.
    Levine TB; Francis GS; Goldsmith SR; Simon AB; Cohn JN
    Am J Cardiol; 1982 May; 49(7):1659-66. PubMed ID: 7044086
    [No Abstract]   [Full Text] [Related]  

  • 43. Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure.
    Dzau VJ
    Am J Cardiol; 1988 Sep; 62(8):76E-81E. PubMed ID: 2901216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activity of the renin-angiotensin-aldosterone and sympathetic nervous system and their relation to hemodynamic and clinical abnormalities in infants with left-to-right shunts.
    Buchhorn R; Ross RD; Bartmus D; Wessel A; Hulpke-Wette M; Bürsch J
    Int J Cardiol; 2001 May; 78(3):225-30; discussion 230-1. PubMed ID: 11376824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurohumoral aspects of heart failure.
    Benedict CR
    Cardiol Clin; 1994 Feb; 12(1):9-23. PubMed ID: 7910114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of the sympathetic nervous system and electrolytes in congestive heart failure.
    Francis GS
    Am J Cardiol; 1990 Mar; 65(10):24E-27E; discussion 52E. PubMed ID: 2309625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroendocrine manifestations of congestive heart failure.
    Francis GS
    Am J Cardiol; 1988 Jul; 62(2):9A-13A. PubMed ID: 3291596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention.
    Guazzi MD; Agostoni P; Perego B; Lauri G; Salvioni A; Giraldi F; Matturri M; Guazzi M; Marenzi G
    Br Heart J; 1994 Dec; 72(6):534-9. PubMed ID: 7857735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.
    Groenning BA; Nilsson JC; Sondergaard L; Kjaer A; Larsson HB; Hildebrandt PR
    Eur J Heart Fail; 2001 Dec; 3(6):699-708. PubMed ID: 11738222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroendocrine activation in congestive heart failure.
    Forfar JC
    Am J Cardiol; 1991 May; 67(12):3C-5C. PubMed ID: 2021117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Neurohormonal factors in heart failure. II].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 May; 49(5):317-27. PubMed ID: 8744385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sympathetic nervous system and endothelial function in heart failure].
    Binggeli C; Wenzel RR; Noll G
    Praxis (Bern 1994); 1996 Feb; 85(8):234-44. PubMed ID: 8701190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopaminergic modulation of physiological and pathological neurohumoral activation in man.
    Smit AJ; Lieverse AG; van Veldhuisen D; Girbes AR
    Hypertens Res; 1995 Jun; 18 Suppl 1():S107-11. PubMed ID: 8529037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction between atrial natriuretic peptide, renin system and vasopressin in heart failure.
    Riegger AJ
    Eur Heart J; 1990 Apr; 11 Suppl B():79-83. PubMed ID: 2142083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alpha-adrenergic component of the sympathetic nervous system in congestive heart failure.
    Leier CV; Binkley PF; Cody RJ
    Circulation; 1990 Aug; 82(2 Suppl):I68-76. PubMed ID: 2164897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology and current therapy of congestive heart failure.
    Parmley WW
    J Am Coll Cardiol; 1989 Mar; 13(4):771-85. PubMed ID: 2647811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurohormonal activation in the treatment of congestive heart failure: basis for new treatments?
    Pool PE
    Cardiology; 1998 Jul; 90(1):1-7. PubMed ID: 9693163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early reduction of neurohumoral factors plays a key role in mediating the efficacy of beta-blocker therapy for congestive heart failure.
    Yoshikawa T; Handa S; Anzai T; Nishimura H; Baba A; Akaishi M; Mitamura H; Ogawa S
    Am Heart J; 1996 Feb; 131(2):329-36. PubMed ID: 8579029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurohumoral pathways in heart failure with preserved systolic function.
    Hogg K; McMurray J
    Prog Cardiovasc Dis; 2005; 47(6):357-66. PubMed ID: 16115515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.